PMID- 23545891
OWN - NLM
STAT- MEDLINE
DCOM- 20140109
LR  - 20221207
IS  - 1945-1997 (Electronic)
IS  - 0098-6151 (Linking)
VI  - 113
IP  - 4 Suppl 2
DP  - 2013 Apr
TI  - Identifying and addressing barriers to insulin acceptance and adherence in 
      patients with type 2 diabetes mellitus.
PG  - S6-16
AB  - Progressive hyperglycemia is a characteristic of type 2 diabetes mellitus (T2DM) 
      that poses a challenge to maintaining optimal glycemic control. Achieving 
      glycemic control early in the course of disease can minimize or prevent serious 
      complications. Most patients with T2DM eventually require insulin replacement 
      therapy to attain and preserve satisfactory glucose control. For decades, the use 
      of insulin to address the primary defect of T2DM has been a cornerstone of 
      diabetes therapy. Insulin is indicated for patients with T2DM presenting with 
      clinically significant hyperglycemia, and it is mandatory for patients exhibiting 
      signs of catabolism. Insulin should be considered for patients in whom 
      hyperglycemia persists despite attempts to control the condition through diet and 
      exercise modifications and the use of noninsulin therapies. Many physicians delay 
      initiation of insulin until absolutely necessary, sometimes overestimating 
      patient concerns about its use. Modern insulin analogs, treatment regimens, and 
      delivery devices make insulin more user friendly, and physicians can promote 
      patient acceptance of insulin by reviewing the benefits of controlled glycated 
      hemoglobin levels and addressing patient concerns.
FAU - Petznick, Allison M
AU  - Petznick AM
AD  - Firelands Regional Medical Center, Sandusky, Ohio, USA. apetznick@gmail.com
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Am Osteopath Assoc
JT  - The Journal of the American Osteopathic Association
JID - 7503065
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (Hypoglycemic Agents)
RN  - 0 (Insulin)
RN  - 0 (hemoglobin A1c protein, human)
SB  - IM
EIN - J Am Osteopath Assoc. 2013 Jul;113(7):507. Dosage error in article text
MH  - Attitude to Health
MH  - Diabetes Mellitus, Type 2/*drug therapy
MH  - Glycated Hemoglobin/analysis
MH  - Humans
MH  - Hypoglycemic Agents/*therapeutic use
MH  - Insulin/*therapeutic use
MH  - *Medication Adherence
MH  - Patient Acceptance of Health Care
MH  - Patient Education as Topic
MH  - Self Care
EDAT- 2013/04/12 06:00
MHDA- 2014/01/10 06:00
CRDT- 2013/04/03 06:00
PHST- 2013/04/03 06:00 [entrez]
PHST- 2013/04/12 06:00 [pubmed]
PHST- 2014/01/10 06:00 [medline]
AID - 113/4_suppl_2/S6 [pii]
PST - ppublish
SO  - J Am Osteopath Assoc. 2013 Apr;113(4 Suppl 2):S6-16.